Crinetics Pharmaceuticals Inc (CRNX) Stock Gains 4.85% This Week: Is It a Good Pick?

Crinetics Pharmaceuticals Inc (CRNX) stock has gained 80.36% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives CRNX stock a score of 77 out of a possible 100.

That rank is primarily influenced by a long-term technical score of 98. CRNX's rank also includes a short-term technical score of 89.

CRNX has an Overall Score of 77. Find out what this means to you and get the rest of the rankings on CRNX!

See Full CRNX Report

What's Happening with CRNX Stock Today

Crinetics Pharmaceuticals Inc (CRNX) stock is higher by 0.62% while the S&P 500 is lower by -0.24% as of 12:34 PM on Thursday, Nov 30. CRNX has gained $0.20 from the previous closing price of $32.03 on volume of 314,461 shares. Over the past year the S&P 500 is higher by 11.26% while CRNX has gained 80.36%. CRNX lost -$3.64 per share in the over the last 12 months. Click Here to get the full Stock Report for Crinetics Pharmaceuticals Inc stock.